InvestorsHub Logo
Followers 139
Posts 8138
Boards Moderated 0
Alias Born 05/06/2009

Re: stockmule post# 253

Tuesday, 11/28/2017 9:35:02 AM

Tuesday, November 28, 2017 9:35:02 AM

Post# of 675
Other Phase 3 results in 1Q 2018. Also, the “failed” study was beneficial to others in the trial so I would assume the application of the drug can be changed/modified for other type of hearing loss. It might bounce, especially at these prices. Just took a 10k share position at .39

idleness is the only refugee of weak minds